AHN Highlights
- Category: Companion animal dental therapy
- Indication: Treatment and support of periodontal health in dogs
- Mechanism: Piezoelectric microcurrents stimulate bone growth and periodontal healing
- Application: Prefilled syringe; UV light curing
- Availability: Pre-order via Patterson Veterinary Supply; shipping expected within 30 days
Phibro Animal Health Corporation has announced the national launch of Restoris™, a piezoelectric dental gel for dogs that uses electric microcurrents to promote bone regeneration and treat periodontal disease. Developed in collaboration with a leading U.S. dental school, Restoris marks a novel approach to veterinary oral care and expands Phibro’s growing portfolio of companion animal therapeutics.
“Restoris is a testament to our commitment to advancing veterinary medicine and supporting the lifelong health of companion animals,” said Jack C. Bendheim, Chairman, President, and CEO of Phibro Animal Health Corporation. “We’re excited to bring this innovative solution to veterinarians and pet owners nationwide.”
A New Approach to Periodontal Health
Periodontal disease affects 80–90% of dogs over age three, often progressing unnoticed until it causes pain, infection, and tooth loss. Left untreated, it can also contribute to systemic conditions such as heart, kidney, and liver disease.
Restoris is applied directly into periodontal pockets using a prefilled syringe and then cured with UV light. Its piezoelectric particles generate microcurrents that stimulate osteoblasts—the cells responsible for bone formation. This process supports new bone growth, reduces periodontal pocket depth, and helps reattach the tooth to healthy tissue.
In laboratory and clinical studies, Restoris demonstrated significant reductions in pocket depth and new alveolar bone formation within 30 days of treatment. The product’s dual mechanism—stimulating bone growth and restoring tissue integrity—targets the disease at its source.
